LP
TYRA icon

LMR Partners’s Tyra Biosciences TYRA Stock Holding History

LMR Partners’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$676K Buy
+21,151
New +$700K ﹤0.01% 1133
2021
Q4 		– Sell
-54,000
Closed -$950K – 1277
2021
Q3 		$950K Buy
+54,000
New +$1.03M 0.01% 667

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

LMR Partners's TYRA Position: Q2 2026 in Review

LMR Partners opened a new position in Tyra Biosciences (TYRA) in Q2 2026: 21,151 shares worth $676K. The stake represents ﹤0.01% of the portfolio and ranks #1133 among its holdings. This is a return to the name: LMR Partners previously reported a position in TYRA as recently as Q3 2021.

LMR Partners first reported a position in TYRA in Q3 2021 and has held it in 2 quarters since. The position peaked at $950K in Q3 2021. 169 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • LMR Partners held 21,151 shares of Tyra Biosciences worth $676K as of Q2 2026.
  • Tyra Biosciences was a new LMR Partners position in Q2 2026.
  • Tyra Biosciences made up ﹤0.01% of LMR Partners's portfolio in Q2 2026, its #1133 holding.
  • LMR Partners first reported a position in Tyra Biosciences in Q3 2021 and has held it in 2 quarters since.
  • LMR Partners's Tyra Biosciences position peaked at $950K in Q3 2021.
  • 169 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on LMR Partners's 13F filing for Q2 2026, filed 14 Aug 2026.